Trademark: Mnemo JETS 2288044
Word
Mnemo JETS
ID
2288044
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
13 January 2022
Registration Date
13 January 2022
Renewal Date
13 January 2032
Owner(s)
Service
Goods and Services:
Class 1:
Biological and chemical products for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions.
Biological and chemical products for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions.
Class 5:
Pharmaceutical preparations; biological and pharmaceutical preparations; biological and pharmaceutical preparations for cancer and tumor treatment using immunotherapy; therapeutic preparations namely antigens, antibodies, T cells; material, preparations, reagents for products for medical use; antigens, antibodies, cells for therapeutic use.
Pharmaceutical preparations; biological and pharmaceutical preparations; biological and pharmaceutical preparations for cancer and tumor treatment using immunotherapy; therapeutic preparations namely antigens, antibodies, T cells; material, preparations, reagents for products for medical use; antigens, antibodies, cells for therapeutic use.
Class 40:
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; manufacture of therapeutic solutions namely antigens, antibodies, T cells.
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; manufacture of therapeutic solutions namely antigens, antibodies, T cells.
Class 42:
Scientific research services for medical purposes; antigen identification, screening and development services; scientific and technological services; scientific laboratory services; providing scientific and medical information with regard to immunotherapy; providing services for identifying, analyzng, authenticating, purifying and developing biological material from a genomic platform; epigenetic antigen screening and identification services for therapeutic research purposes; genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses.
Scientific research services for medical purposes; antigen identification, screening and development services; scientific and technological services; scientific laboratory services; providing scientific and medical information with regard to immunotherapy; providing services for identifying, analyzng, authenticating, purifying and developing biological material from a genomic platform; epigenetic antigen screening and identification services for therapeutic research purposes; genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses.